Results 171 to 180 of about 39,011 (251)
Continuous 28‐day light exposure alters behaviours of articular cartilage progenitor cells (ACPCs) and mesenchymal stromal cells (MSCs). Co‐culture with Leptolyngbya and Synechococcus does not adversely affect the chondrogenic capacity of ACPCs over a 28‐day period, in contrast to co‐culture with Chlorella.
Meng Wang +10 more
wiley +1 more source
Abstract Aims To explore how gestational diabetes mellitus (GDM) and disordered eating behaviours (DEBs) in pregnancy and postpartum are discussed on an online forum. Methods A qualitative reflexive thematic analysis of threads and comments from publicly accessible Reddit forums.
Yasaman Noori +4 more
wiley +1 more source
Unravelling dialysis‐related dysglycaemia: Longitudinal insights from continuous glucose monitoring
Abstract Aim To characterise CGM‐derived glycaemic trajectories over 12months in people receiving maintenance haemodialysis, with a particular focus on hypoglycaemia burden and composite glycaemic risk. Methods We conducted a longitudinal observational study. CGM data were collected at baseline, 6 and 12 months.
Hellena Hailu Habte‐Asres +4 more
wiley +1 more source
Higher glycaemic burden, measured by the Glycaemic Penalty Index (GPI), was independently associated with increased risk of healthcare‐associated infection in surgical inpatients. GPI provides a single, clinically interpretable summary of both hyperglycaemia and hypoglycaemia. Abstract Aims To evaluate the utility of the Glycemic Penalty Index (GPI), a
Gabrielle Blomson +7 more
wiley +1 more source
Abstract Aims The type 1 diabetes population is ageing. Frailty is the age‐related physiological decline that occurs across organ systems, increasing the body's vulnerability to stressors. Current consensus‐based guidelines, derived from evidence in type 2 diabetes, prioritise hypoglycaemia avoidance, which increases falls, hospitalisation and ...
Jonathan A. Golding +5 more
wiley +1 more source
Driving-Related Glucose Monitoring Practices Among Insulin-Treated Adults With Type 2 Diabetes. [PDF]
Barnard-Kelly K +6 more
europepmc +1 more source
Abstract Aims CGM devices report glucose only within fixed limits (typically 40–400 mg/dL; 2.2–22.2 mmol/L), truncating extreme values to a boundary (‘capping’). We characterised prevalence, duration, and consequences of capping in type 1 diabetes trial data.
John F. Mulley
wiley +1 more source
Portable Home-Use Triglyceride Meter Demonstrates Good Agreement With Plasma Laboratory Measures During Pregnancies Complicated by Metabolic Disease. [PDF]
Farabi SS +11 more
europepmc +1 more source
ABSTRACT Aims This post hoc analysis of COMBINE 1–3 assessed efficacy and hypoglycaemia outcomes with IcoSema (once‐weekly combination therapy of basal insulin icodec and semaglutide [a glucagon‐like peptide‐1 analogue]) versus comparators in adults with type 2 diabetes (T2D) by kidney and liver function subgroups.
Linong Ji +6 more
wiley +1 more source
Performance of New Roche Cobas Pulse Glucose Meter Against Potential Interfering Substances and Hematocrit Variations. [PDF]
Pudineh Moarref M, Black W, Chen Y.
europepmc +1 more source

